Journal of Ocular Pharmacology and Therapeutics · 2002 · 75 citations · 18 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryOcular Drug DeliveryOphthalmic Drug DeliveryDrug Delivery SystemsPermeability AssessmentPermeability EnhancementTransscleral Drug DeliveryDrug PermeabilityDrug Permeation Across ScleraFluorescent DyesScleral Barrier TransportScleral Drug DiffusionScleral PermeationScleral Transport KineticsSolubility
PURPOSE: To determine the in vitro human scleral permeability of several dyes and drugdye combinations with varying molecular weights (MW) and lipid solubilities (fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein, and rhodamine). Coils coated with rhodamine were also evaluated for scleral permeability and sustained release. METHODS: Scleral sections excised from moist chamber stored human globes were mounted in a 2-compartment perfusion chamber. A small depot of drug/dye (100 microl of 10(-4) M fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein or rhodamine) or a coated coil in 100 microl of BSS was added to the episcleral surface while perfusing BSS to the choroidal side. The perfusate was collected and measured for fluorescence. Permeability was calculated as Ktrans from the flux measurements. RESULTS: Ktrans values (cm/sec, mean +/- SE) for the studied dyes and drug-dye combinations were 5.21 +/- 0.71 x 10(-6) for fluorescein, 1.64 +/- 0.17 x 10(-6) for dexamethasone-fluorescein, 3.36 +/- 0.62 x 10(-6) for methotrexate-fluorescein, 1.86 +/- 0.39 x 10(-6) for rhodamine and 2.18 +/- 0.23 x 10(-6) for the rhodamine from the coils. We found a significant difference between the permeability of the sclera to fluorescein and dexamethasone-fluorescein (P < 0.001), methotrexate-fluorescein (P < 0.05) and rhodamine (P < 0.001). Steady state flux was observed from the rhodamine coil. CONCLUSION: The rank order of scleral permeability to the studied dyes is as follows: fluorescein > methotrexate-fluorescein > rhodamine coil > rhodamine 6G > dexamethasone-fluorescein. Differences in scleral permeability are related to MW and lipid solubility. Prolonged transscleral diffusion of rhodamine delivered by solution and by coil are similar.
18
Diffusion of high molecular weight compounds through sclera.
Jayakrishna Ambati, Christina Canakis, Joan W. Miller et al. · PubMed · 2000 · 360 citations
Pharmacy, Biochemistry, Biomaterials +13
Ocular drug delivery conventional ocular formulations
John C. Lang · Advanced Drug Delivery Reviews · 1995 · 356 citations
Human sclera: Thickness and surface area
Timothy W. Olsen, S Aaberg, Dayle H. Geroski et al. · American Journal of Ophthalmology · 1998 · 352 citations
Drug delivery for posterior segment eye disease.
Dayle H. Geroski, H. F. Edelhauser · PubMed · 2000 · 342 citations
Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
Kirsi Hämäläinen, Kirsi Kananen, Seppo Auriola et al. · PubMed · 1997 · 267 citations